Prognostic impact and therapeutic implications of sentinel lymph node micro-metastases in early-stage breast cancer patients

Journal of Surgical Oncology

Volumn 103, Issue 6, 2011, Pages 531-533

  Viehl, Carsten T ^a   Langer, Igor ^a,c   Guller, Ulrich ^a,d   Zanetti Dällenbach, Rosanna ^a   Moch, Holger ^b   Wight, Edward ^a   Oertli, Daniel ^a   Zuber, Markus ^c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Kantonsspital Olten ^*  (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

axillary lymph node dissection; breast cancer; lymphatic micrometastasis; sentinel lymph node procedure; treatment outcome

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RECURRENCE; CANCER STAGING; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MEDICAL LITERATURE; PRIORITY JOURNAL; PROGNOSIS;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME;

EID: 79953875930     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21693     Document Type: Article

References (25)

1. Langer I, Guller U, Berclaz G, et al.: Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: A prospective Swiss multicenter study on 659 patients. Ann Surg 2007; 245: 452-461. (Pubitemid 46673142)
2. Veronesi U, Viale G, Paganelli G, et al.: Sentinel lymph node biopsy in breast cancer: Ten-year results of a randomized controlled study. Ann Surg 2010; 251: 595-600.
3. Wasif N, Ye X, Giuliano AE,: Survey of ASCO members on management of sentinel node micrometastases in breast cancer: Variation in treatment recommendations according to specialty. Ann Surg Oncol 2009; 16: 2442-2449.
4. Langer I, Guller U, Viehl CT, et al.: Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: Long-term outcomes of a prospective study. Ann Surg Oncol 2009; 16: 3366-3374.
5. Langer I, Marti WR, Guller U, et al.: Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: Prospective analysis of 150 patients after SLN biopsy. Ann Surg 2005; 241: 152-158. (Pubitemid 40041004)
6. Goldhirsch A, Glick JH, Gelber RD, et al.: Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 2001; 19: 3817-3827. (Pubitemid 32880060)
7. Goldhirsch A, Glick JH, Gelber RD, et al.: Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. J Natl Cancer Inst 1998; 90: 1601-1608. (Pubitemid 28523434)
8. Guller U, Langer I, Zuber M,: In Reply: Micrometastases in breast cancer sentinel lymph node. Ann Surg Oncol 2010; 17: 938.
9. de Boer M, van Deurzen CH, van Dijck JA, et al.: Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 2009; 361: 653-663.
10. Bilimoria KY, Bentrem DJ, Stewart AK, et al.: Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: Implications for studies that use the National Cancer Data Base. J Clin Oncol 2009; 27: 4177-4181.
11. Liang WC, Sickle-Santanello BJ, Nims TA,: Is a completion axillary dissection indicated for micrometastases in the sentinel lymph node? Am J Surg 2001; 182: 365-368. (Pubitemid 33079088)
12. Ganaraj A, Kuhn JA, Jones RC, et al.: Predictors for nonsentinel node involvement in breast cancer patients with micrometastases in the sentinel lymph node. Proc (Bayl Univ Med Cent) 2003; 16: 3-6.
13. Guenther JM, Hansen NM, DiFronzo LA, et al.: Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg 2003; 138: 52-56. (Pubitemid 36055648)
14. Fant JS, Grant MD, Knox SM, et al.: Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol 2003; 10: 126-130. (Pubitemid 40485931)
15. Fournier K, Schiller A, Perry RR, et al.: Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection. Ann Surg 2004; 239: 859-863.
16. Fan YG, Tan YY, Wu CT, et al.: The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer. Ann Surg Oncol 2005; 12: 705-711.
17. Schrenk P, Konstantiniuk P, Wolfl S, et al.: Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node. Br J Surg 2005; 92: 707-713. (Pubitemid 40863189)
18. Carlo JT, Grant MD, Knox SM, et al.: Survival analysis following sentinel lymph node biopsy: A validation trial demonstrating its accuracy in staging early breast cancer. Proc (Bayl Univ Med Cent) 2005; 18: 103-107.
19. Chagpar A, Middleton LP, Sahin AA, et al.: Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer 2005; 103: 1581-1586. (Pubitemid 40490018)
20. Haid A, Knauer M, Koberle-Wuhrer R, et al.: Medium-term follow-up data after sentinel node biopsy alone for breast cancer. Eur J Surg Oncol 2006; 32: 1180-1185. (Pubitemid 44793674)
21. Hwang RF, Gonzalez-Angulo AM, Yi M, et al.: Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer 2007; 110: 723-730. (Pubitemid 47257646)
22. Pernas S, Gil M, Benitez A, et al.: Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: A prospective analysis of axillary or distant recurrence. Ann Surg Oncol 2010; 17: 772-777.
23. Pugliese MS, Karam AK, Hsu M, et al.: Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer. Ann Surg Oncol 2010; 17: 1063-1068.
24. Giuliano A, McCall L, Beitsch P, et al.: Locoregional recurrence after sentinel lymph node dissection with or without auxillary dissection in patients with sentinel lymph node metastases. The American College of Surgeons Oncology Z0011 Randomized Trial. Ann Surg 2010; 252: 426-433.
25. Giuliano AE, Hunt KK, Ballman KV, et al.: Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial. JAMA 2011; 305: 569-575.